CN Stock MarketDetailed Quotes

301277 Newland Pharmaceutical

Watchlist
  • 14.53
  • -0.11-0.75%
Trading Oct 16 09:32 CST
4.07BMarket Cap23.03P/E (TTM)

Newland Pharmaceutical Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

All
YOY yoy
Hide blank lines yoy
(Q6)Jun 30, 2024
(Q3)Mar 31, 2024
(FY)Dec 31, 2023
(Q9)Sep 30, 2023
(Q6)Jun 30, 2023
(Q3)Mar 31, 2023
(FY)Dec 31, 2022
(Q9)Sep 30, 2022
(Q6)Jun 30, 2022
(Q3)Mar 31, 2022
Total operating revenue
18.74%396.76M
6.98%184.58M
3.84%651.44M
9.33%490.1M
-3.78%334.15M
7.54%172.54M
22.09%627.36M
37.06%448.29M
33.82%347.27M
39.43%160.45M
Operating revenue
18.74%396.76M
6.98%184.58M
3.84%651.44M
9.33%490.1M
-3.78%334.15M
7.54%172.54M
22.09%627.36M
37.06%448.29M
33.82%347.27M
39.43%160.45M
Other operating revenue
-10.19%2.94M
----
23.34%7.59M
----
8.61%3.28M
----
25.30%6.15M
----
31.14%3.02M
----
Total operating cost
13.32%273.44M
-0.48%127.02M
1.45%492.35M
2.80%357.81M
-8.12%241.3M
7.00%127.64M
30.11%485.33M
43.79%348.05M
43.60%262.62M
119.29M
Operating cost
13.40%225.28M
-2.05%104.17M
-2.99%391.92M
-0.56%290.47M
-12.12%198.66M
2.19%106.36M
31.25%404.01M
50.79%292.1M
52.08%226.06M
--104.08M
Operating tax surcharges
-11.18%3.26M
-4.59%1.62M
-5.89%6.57M
-2.21%5.41M
-17.04%3.68M
-15.04%1.69M
9.12%6.99M
32.64%5.53M
34.68%4.43M
--1.99M
Operating expense
53.28%2.08M
36.48%821.58K
80.23%4.86M
44.81%2.51M
15.82%1.36M
19.32%601.97K
28.32%2.7M
26.55%1.73M
43.74%1.17M
--504.48K
Administration expense
-5.94%18.65M
-14.55%9.57M
9.66%39.62M
31.54%30.76M
30.01%19.82M
58.23%11.2M
22.65%36.13M
5.42%23.38M
-2.29%15.25M
--7.08M
Financial expense
-259.63%-1.77M
-406.64%-1.15M
-147.19%-2.6M
-119.30%-934.65K
-114.42%-491.71K
-113.92%-226.29K
-17.28%5.5M
-0.49%4.84M
10.34%3.41M
--1.63M
-Interest expense (Financial expense)
-77.35%175.96K
-43.41%33.22K
-98.07%132.85K
-90.11%524.59K
-78.45%776.94K
-96.48%58.7K
2.63%6.88M
9.46%5.31M
19.68%3.61M
--1.67M
-Interest Income (Financial expense)
-96.54%-1.84M
-223.10%-1.14M
-130.40%-2.7M
-298.02%-1.42M
-397.40%-936.9K
-304.71%-353.17K
-357.88%-1.17M
-102.44%-357.21K
-132.21%-188.36K
---87.26K
Research and development
41.92%25.94M
49.59%11.99M
73.19%51.96M
44.65%29.61M
48.54%18.28M
99.95%8.02M
45.72%30M
29.92%20.47M
7.54%12.3M
--4.01M
Credit Impairment Loss
-174.84%-2.38M
-119.23%-659.41K
257.71%3.52M
583.45%2.76M
175.70%3.18M
263.13%3.43M
79.94%-2.23M
-153.50%-571.06K
-183.41%-4.2M
---2.1M
Asset Impairment Loss
-607.55%-1.76M
---862.61K
---914.6K
---588.01K
---248.41K
----
----
----
----
----
Other net revenue
-51.60%6.05M
-64.54%2.93M
3,959.30%23.67M
5,006.69%16.8M
468.07%12.5M
518.20%8.26M
107.03%583.09K
-90.37%329.07K
-86,133.04%-3.4M
-1.98M
Fair value change income
110.27%74.86K
45.59%-228.62K
-96.97%41.06K
-0.36%142.48K
-783.30%-728.81K
-779.42%-420.17K
715.67%1.36M
39.07%143K
191.21%106.66K
--61.84K
Invest income
-26.87%7.28M
-30.21%3.62M
10,030.79%16.92M
--13.74M
--9.96M
--5.18M
7,725.57%167.03K
----
----
----
Asset deal income
----
----
115.12%66.94K
----
----
----
-114.11%-442.73K
---442.73K
----
----
Other revenue
742.86%2.83M
1,398.25%1.06M
132.58%4.04M
-37.53%749.51K
-51.85%335.34K
10.25%70.97K
-39.46%1.74M
-46.51%1.2M
-51.59%696.44K
--64.37K
Operating profit
22.80%129.37M
13.77%60.49M
28.14%182.76M
48.24%149.09M
29.65%105.35M
35.68%53.17M
7.63%142.62M
13.72%100.57M
6.04%81.25M
10.53%39.19M
Add:Non operating Income
-52.42%8.57K
-89.88%1.7K
-98.00%13.97K
-93.23%47.06K
-97.41%18.02K
-88.61%16.8K
1,695.44%698.42K
4,238.03%695.24K
5,302.62%694.98K
--147.51K
Less:Non operating expense
260.40%674.37K
28.72%173.95K
269.54%1.61M
269.63%929.01K
141.22%187.12K
--135.14K
-29.62%434.77K
-54.02%251.34K
-80.81%77.57K
----
Total profit
22.37%128.7M
13.70%60.32M
26.79%181.16M
46.72%148.21M
28.47%105.18M
34.87%53.05M
8.30%142.88M
14.91%101.01M
7.39%81.87M
10.95%39.33M
Less:Income tax cost
52.01%18.2M
-24.87%4.93M
114.45%23.96M
3.41%12.55M
13.41%11.97M
21.09%6.56M
-34.70%11.17M
9.32%12.14M
4.09%10.56M
--5.42M
Net profit
18.56%110.5M
19.15%55.39M
19.36%157.2M
52.63%135.66M
30.70%93.2M
37.07%46.49M
14.70%131.71M
15.72%88.88M
7.90%71.31M
9.66%33.91M
Net profit from continuing operation
18.56%110.5M
----
19.36%157.2M
52.63%135.66M
30.70%93.2M
----
14.70%131.71M
--88.88M
--71.31M
--33.91M
Less:Minority Profit
-95.83%-999.9K
-128.32%-530.5K
-197.82%-1.78M
-147.86%-1.03M
-86.72%-510.6K
-67.19%-232.35K
-286.25%-596.75K
-391.37%-413.62K
-9,096.05%-273.46K
---138.97K
Net profit of parent company owners
18.98%111.5M
19.69%55.92M
20.16%158.98M
53.07%136.68M
30.91%93.71M
37.19%46.72M
15.07%132.3M
16.13%89.29M
8.30%71.58M
10.11%34.05M
Earning per share
Basic earning per share
21.21%0.4
21.74%0.28
-8.14%0.79
-23.47%0.6833
-54.17%0.33
-32.35%0.23
-25.22%0.86
15.96%0.8929
9.09%0.72
--0.34
Diluted earning per share
21.21%0.4
21.74%0.28
-8.14%0.79
-23.47%0.6833
-54.17%0.33
-32.35%0.23
-25.22%0.86
15.96%0.8929
9.09%0.72
--0.34
Other composite income
Total composite income
18.56%110.5M
19.15%55.39M
19.36%157.2M
52.63%135.66M
30.70%93.2M
37.07%46.49M
14.70%131.71M
15.72%88.88M
7.90%71.31M
33.91M
Total composite income of parent company owners
18.98%111.5M
19.69%55.92M
20.16%158.98M
53.07%136.68M
30.91%93.71M
37.19%46.72M
15.07%132.3M
16.13%89.29M
8.30%71.58M
--34.05M
Total composite income of minority owners
-95.83%-999.9K
-128.32%-530.5K
-197.82%-1.78M
-147.86%-1.03M
-86.72%-510.6K
-67.19%-232.35K
-286.25%-596.75K
-391.37%-413.62K
-9,096.05%-273.46K
---138.97K
Currency Unit
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
Accounting Standards
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
Audit Opinions
--
--
Unqualified opinion
--
--
--
Unqualified opinion
--
--
--
Auditor
--
--
Grant Tung Certified Public Accountants (Special General Partnership)
--
--
--
KPMG Huazhen Certified Public Accountants (Special General Partnership)
--
--
--
(Q6)Jun 30, 2024(Q3)Mar 31, 2024(FY)Dec 31, 2023(Q9)Sep 30, 2023(Q6)Jun 30, 2023(Q3)Mar 31, 2023(FY)Dec 31, 2022(Q9)Sep 30, 2022(Q6)Jun 30, 2022(Q3)Mar 31, 2022
Total operating revenue 18.74%396.76M6.98%184.58M3.84%651.44M9.33%490.1M-3.78%334.15M7.54%172.54M22.09%627.36M37.06%448.29M33.82%347.27M39.43%160.45M
Operating revenue 18.74%396.76M6.98%184.58M3.84%651.44M9.33%490.1M-3.78%334.15M7.54%172.54M22.09%627.36M37.06%448.29M33.82%347.27M39.43%160.45M
Other operating revenue -10.19%2.94M----23.34%7.59M----8.61%3.28M----25.30%6.15M----31.14%3.02M----
Total operating cost 13.32%273.44M-0.48%127.02M1.45%492.35M2.80%357.81M-8.12%241.3M7.00%127.64M30.11%485.33M43.79%348.05M43.60%262.62M119.29M
Operating cost 13.40%225.28M-2.05%104.17M-2.99%391.92M-0.56%290.47M-12.12%198.66M2.19%106.36M31.25%404.01M50.79%292.1M52.08%226.06M--104.08M
Operating tax surcharges -11.18%3.26M-4.59%1.62M-5.89%6.57M-2.21%5.41M-17.04%3.68M-15.04%1.69M9.12%6.99M32.64%5.53M34.68%4.43M--1.99M
Operating expense 53.28%2.08M36.48%821.58K80.23%4.86M44.81%2.51M15.82%1.36M19.32%601.97K28.32%2.7M26.55%1.73M43.74%1.17M--504.48K
Administration expense -5.94%18.65M-14.55%9.57M9.66%39.62M31.54%30.76M30.01%19.82M58.23%11.2M22.65%36.13M5.42%23.38M-2.29%15.25M--7.08M
Financial expense -259.63%-1.77M-406.64%-1.15M-147.19%-2.6M-119.30%-934.65K-114.42%-491.71K-113.92%-226.29K-17.28%5.5M-0.49%4.84M10.34%3.41M--1.63M
-Interest expense (Financial expense) -77.35%175.96K-43.41%33.22K-98.07%132.85K-90.11%524.59K-78.45%776.94K-96.48%58.7K2.63%6.88M9.46%5.31M19.68%3.61M--1.67M
-Interest Income (Financial expense) -96.54%-1.84M-223.10%-1.14M-130.40%-2.7M-298.02%-1.42M-397.40%-936.9K-304.71%-353.17K-357.88%-1.17M-102.44%-357.21K-132.21%-188.36K---87.26K
Research and development 41.92%25.94M49.59%11.99M73.19%51.96M44.65%29.61M48.54%18.28M99.95%8.02M45.72%30M29.92%20.47M7.54%12.3M--4.01M
Credit Impairment Loss -174.84%-2.38M-119.23%-659.41K257.71%3.52M583.45%2.76M175.70%3.18M263.13%3.43M79.94%-2.23M-153.50%-571.06K-183.41%-4.2M---2.1M
Asset Impairment Loss -607.55%-1.76M---862.61K---914.6K---588.01K---248.41K--------------------
Other net revenue -51.60%6.05M-64.54%2.93M3,959.30%23.67M5,006.69%16.8M468.07%12.5M518.20%8.26M107.03%583.09K-90.37%329.07K-86,133.04%-3.4M-1.98M
Fair value change income 110.27%74.86K45.59%-228.62K-96.97%41.06K-0.36%142.48K-783.30%-728.81K-779.42%-420.17K715.67%1.36M39.07%143K191.21%106.66K--61.84K
Invest income -26.87%7.28M-30.21%3.62M10,030.79%16.92M--13.74M--9.96M--5.18M7,725.57%167.03K------------
Asset deal income --------115.12%66.94K-------------114.11%-442.73K---442.73K--------
Other revenue 742.86%2.83M1,398.25%1.06M132.58%4.04M-37.53%749.51K-51.85%335.34K10.25%70.97K-39.46%1.74M-46.51%1.2M-51.59%696.44K--64.37K
Operating profit 22.80%129.37M13.77%60.49M28.14%182.76M48.24%149.09M29.65%105.35M35.68%53.17M7.63%142.62M13.72%100.57M6.04%81.25M10.53%39.19M
Add:Non operating Income -52.42%8.57K-89.88%1.7K-98.00%13.97K-93.23%47.06K-97.41%18.02K-88.61%16.8K1,695.44%698.42K4,238.03%695.24K5,302.62%694.98K--147.51K
Less:Non operating expense 260.40%674.37K28.72%173.95K269.54%1.61M269.63%929.01K141.22%187.12K--135.14K-29.62%434.77K-54.02%251.34K-80.81%77.57K----
Total profit 22.37%128.7M13.70%60.32M26.79%181.16M46.72%148.21M28.47%105.18M34.87%53.05M8.30%142.88M14.91%101.01M7.39%81.87M10.95%39.33M
Less:Income tax cost 52.01%18.2M-24.87%4.93M114.45%23.96M3.41%12.55M13.41%11.97M21.09%6.56M-34.70%11.17M9.32%12.14M4.09%10.56M--5.42M
Net profit 18.56%110.5M19.15%55.39M19.36%157.2M52.63%135.66M30.70%93.2M37.07%46.49M14.70%131.71M15.72%88.88M7.90%71.31M9.66%33.91M
Net profit from continuing operation 18.56%110.5M----19.36%157.2M52.63%135.66M30.70%93.2M----14.70%131.71M--88.88M--71.31M--33.91M
Less:Minority Profit -95.83%-999.9K-128.32%-530.5K-197.82%-1.78M-147.86%-1.03M-86.72%-510.6K-67.19%-232.35K-286.25%-596.75K-391.37%-413.62K-9,096.05%-273.46K---138.97K
Net profit of parent company owners 18.98%111.5M19.69%55.92M20.16%158.98M53.07%136.68M30.91%93.71M37.19%46.72M15.07%132.3M16.13%89.29M8.30%71.58M10.11%34.05M
Earning per share
Basic earning per share 21.21%0.421.74%0.28-8.14%0.79-23.47%0.6833-54.17%0.33-32.35%0.23-25.22%0.8615.96%0.89299.09%0.72--0.34
Diluted earning per share 21.21%0.421.74%0.28-8.14%0.79-23.47%0.6833-54.17%0.33-32.35%0.23-25.22%0.8615.96%0.89299.09%0.72--0.34
Other composite income
Total composite income 18.56%110.5M19.15%55.39M19.36%157.2M52.63%135.66M30.70%93.2M37.07%46.49M14.70%131.71M15.72%88.88M7.90%71.31M33.91M
Total composite income of parent company owners 18.98%111.5M19.69%55.92M20.16%158.98M53.07%136.68M30.91%93.71M37.19%46.72M15.07%132.3M16.13%89.29M8.30%71.58M--34.05M
Total composite income of minority owners -95.83%-999.9K-128.32%-530.5K-197.82%-1.78M-147.86%-1.03M-86.72%-510.6K-67.19%-232.35K-286.25%-596.75K-391.37%-413.62K-9,096.05%-273.46K---138.97K
Currency Unit CNYCNYCNYCNYCNYCNYCNYCNYCNYCNY
Accounting Standards CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)
Audit Opinions ----Unqualified opinion------Unqualified opinion------
Auditor ----Grant Tung Certified Public Accountants (Special General Partnership)------KPMG Huazhen Certified Public Accountants (Special General Partnership)------

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
CN
Overall
Symbol
Latest Price
% Chg

No Data